CTRI/2023/02/049952
Not yet recruiting
Phase 3
Open Labeled Randomized controlled Trial TO Compare The Effect Of Agnikarma And Viddha-Agnikarma In Vatakantak (Plantar Fasciitis)
Dr Anjali Subhashrao Suryawanshi0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Anjali Subhashrao Suryawanshi
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Clinically diagnosed Patients of Vatakantaka (plantar fasciitis)
- •2\. Age group more than 18 years.
- •3\. Selection will be irrespective of gender, religion and socio\-economic status
Exclusion Criteria
- •1\. Uncontrolled systemic diseases like diabetes mellitus, hypertension.
- •2\. Fracture of calcaneum.
- •3\. Other pathologies like osteomyelitis of calcaneum.
- •4\. Immuno\-compromised Patients.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
ocal application of sehund latex mixed with haldi powder for treatment of pilesHealth Condition 1: K641- Second degree hemorrhoidsCTRI/2023/02/049718Dr Akanksha Ravindra Rangari
Not yet recruiting
Not Applicable
EVETERACETAM VS SODIUM VALPROATEHealth Condition 1: G409- Epilepsy, unspecifiedCTRI/2020/09/027792government medical college and hospital aurangabad
Active, not recruiting
Not Applicable
Randomised, controlled open label trial to compare the efficacy safety and tolerability of a treatment simplification by darunavir/ritonavir DRV/r 800/100 mg OD vs a triple combination therapy containing DRV/r in HIV-1 infected subjects with undetectable plasma HIV-1 RNA on their current treatments - TMC114HIV3006HIV-1 patients with plasma RNA HIV-1 undetectable in current treatmentMedDRA version: 9.1Level: LLTClassification code 10049829Term: Blood HIV RNA below assay limitEUCTR2006-006437-40-ITJANSSEN-CILAG INTERNATIONAL N.V.250
Active, not recruiting
Phase 1
Open label Randomised Controlled Trial comparing povidone-iodine 10% with alcohol and 0.5% chlorhexidine with alcohol for prevention of early infection associated with insertion of central venous access devices - RCT for the prevention of early CVAD InfectioPotential Systematic SepsisEUCTR2006-000675-15-GBGreat Ormond Street Hospital for Children NHS Trust500
Recruiting
Phase 3
A study to examine whether giving steroids in low dose daily is more effective than if given on alternate days, in controlling disease activity in patients with frequently relapsing nephrotic syndromeCTRI/2019/01/017091Indian Council of Medical Research